Solara Active Pharma Sciences Limited has informed the exchange regarding appointment of Mr. Mohanraj S(DIN: 08420411) as Additional Executive Director and Whole Time Director with effect from January 01, 2026.

pdf

Solara Active Pharma Sciences Ltd.

17 Dec 2025

560.05

0.31%

Corp. Note

Solara Active Pharma Sciences Ltd - 541540 - Board Meeting Outcome for Board Meeting Outcome For …

BSE India

Solara Active Pharma Sciences Limited has informed the Exchange regarding Board Meeting held on December 17, 2025 inter alia to consider appointment of Mr. Mohanraj. S (DIN:08420411) as Additional Executive Director and Whole Time Director

pdf

Solara Active Pharma Sciences Ltd.

05 Dec 2025

560.05

0.31%

Company Update

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Resignation of Director

BSE India

Solara Active Pharma Sciences Limited has informed the exchange regarding the Resignation of Mr. Mohan Muthunarayanan (DIN: 03610282),Whole Time Director & Chief Operating Officer of the company with effect from the end of business hours on December 31, 2025.

pdf

Solara Active Pharma Sciences Ltd.

04 Dec 2025

560.05

0.31%

Company Update

Solara Active Pharma Sciences Ltd - 541540 - Clarification On Volume Movement

BSE India

Clarification in relation to the mail received from exchange on December 04, 2025 on Volume Movement.

pdf

Solara Active Pharma Sciences Ltd.

04 Dec 2025

560.05

0.31%

Company Update

Solara Active Pharma Sciences Ltd - 541540 - Clarification sought from Solara Active Pharma Sciences Ltd

BSE India

The Exchange has sought clarification from Solara Active Pharma Sciences Ltd on December 04, 2025, with reference to Movement in Volume. The reply is awaited.

Solara Active Pharma Sciences Ltd.

19 Nov 2025

560.05

0.31%

Company Update

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Press Release / Media …

BSE India

Solara Active Pharma Sciences Limited has informed the exchange about the Press release titled "Solara is pleased to announce the successful closure of US FDA inspection of its Mangalore facility with continued state of compliance on cGMP."

pdf

Solara Active Pharma Sciences Ltd.

11 Nov 2025

560.05

0.31%

Earnings Call

Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Solara Active Pharma Sciences Limited has informed the exchange regarding the Earnings Call Transcript pertaining to unaudited financial results of the company for the quarter and half year ended September 30, 2025

pdf

Is Solara Active Pharma Sciences Ltd. worth buying?

182 Votes:

Buy 80.22%

Sell 13.74%

Hold 6.04%